Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway: Complete Statistical AnalysisIndependent statistical analysis of Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on…
- Four Week Performance Comparison Between Two Commercially Available Silicone Hydrogel Lenses: Complete Statistical AnalysisIndependent statistical analysis of Four Week Performance Comparison Between Two Commercially Available Silicone Hydrogel Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FOXIndependent statistical analysis of Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use: primary endpoint results, effect estimate with confidence interval, sample-size…
- FOXFIREGlobalIndependent statistical analysis of FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FPF in AMDIndependent statistical analysis of Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06381596).
- FPNG+Independent statistical analysis of The Impact of a Parenting Intervention on Latino Youth Health Behaviors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FPSIndependent statistical analysis of Effects of Obesity Treatments on Food Preferences and Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01724060).
- FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383565).
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma: Complete Statistical AnalysisIndependent statistical analysis of FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection: Complete Statistical AnalysisIndependent statistical analysis of Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04301934).
- Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI: Complete Statistical AnalysisIndependent statistical analysis of Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Fractionated Stereotactic Radiosurgery for Large Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Fractionated Stereotactic Radiosurgery for Large Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02054689).
- Fracture Risk With Thiazolidinediones: Complete Statistical AnalysisIndependent statistical analysis of Fracture Risk With Thiazolidinediones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01055223).
- FREAPIndependent statistical analysis of Effectiveness of Standardized Respiratory Physiotherapy in Primary Care (FREAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01152762).
- FREEDOMIndependent statistical analysis of the FREEDOM trial comparing coronary artery bypass grafting with percutaneous coronary intervention in individuals with diabetes and multivessel coronary artery disease, including time-to-event methods, reported results, safety, and…
- FREEDOMIndependent statistical analysis of A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FREEDOMSIndependent statistical analysis of Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FREEDOMS IIIndependent statistical analysis of Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FREEOAB Study for Overactive Bladder: Complete Statistical AnalysisIndependent statistical analysis of FREEOAB Study for Overactive Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04547920).
- FREESIAIndependent statistical analysis of Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV): primary endpoint results, effect…
- FreezeAFIndependent statistical analysis of PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Fremanezumab, Migraine and Sleep: Complete Statistical AnalysisIndependent statistical analysis of Fremanezumab, Migraine and Sleep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04693533).
- Frequency of Denture Cleanser Use and Denture Cleanliness: Complete Statistical AnalysisIndependent statistical analysis of Frequency of Denture Cleanser Use and Denture Cleanliness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02780661).
- FRESCO-2Independent statistical analysis of the phase 3 FRESCO-2 trial of fruquintinib plus best supportive care versus placebo plus best supportive care in metastatic colorectal cancer, including overall survival, progression-free survival, response, statistical…
- FRESCO-2Independent statistical analysis of A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FRESHIndependent statistical analysis of FimasaRtan-basEd BP Targets After Drug SwitcHing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03649646).
- FRESHIndependent statistical analysis of FRESH Study (Fitness, Relaxation and Eating to Stay Healthy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01636258).
- FRESHIndependent statistical analysis of Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fresh Versus Old Red Blood Cells for Transfusion: Complete Statistical AnalysisIndependent statistical analysis of Fresh Versus Old Red Blood Cells for Transfusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01319552).
- Fresolimumab and Radiotherapy in Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fresolimumab and Radiotherapy in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01401062).
- Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): Complete Statistical AnalysisIndependent statistical analysis of Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- From Innovation to Solutions: Childhood Influenza Vaccination Planning: Complete Statistical AnalysisIndependent statistical analysis of From Innovation to Solutions: Childhood Influenza Vaccination Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664793).
- From Short-term Surgical Missions Towards Sustainable Partnerships: Complete Statistical AnalysisIndependent statistical analysis of From Short-term Surgical Missions Towards Sustainable Partnerships: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04450823).
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Frontal and Parietal Contributions to Proprioception and Motor Skill Learning: Complete Statistical AnalysisIndependent statistical analysis of Frontal and Parietal Contributions to Proprioception and Motor Skill Learning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05739994).
- FRONTIERIndependent statistical analysis of Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FRONTIER 1Independent statistical analysis of A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05223868).
- FRONTIER-3Independent statistical analysis of Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FRONTIER-IIndependent statistical analysis of Safety and Performance Study of Large Hole Vascular Closure Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01943344).
- FROSTYIndependent statistical analysis of Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FROZEN-AFIndependent statistical analysis of Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FSHDIndependent statistical analysis of Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FSSTIndependent statistical analysis of Family Supportive Supervisor Training and Workplace Assessment Tool: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05080426).
- FTCIndependent statistical analysis of Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir: Complete Statistical AnalysisIndependent statistical analysis of FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FuchsIndependent statistical analysis of A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy: primary endpoint results, effect estimate…
- Fucidin® Cream in the Treatment of Impetigo: Complete Statistical AnalysisIndependent statistical analysis of Fucidin® Cream in the Treatment of Impetigo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986856).
- FUELExtenIndependent statistical analysis of A Extension Study of Udenafil in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03013751).
- Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543127).
- Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617188).